Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia 6Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Acute 3Hematologic Diseases 3Leukemia, Promyelocytic, Acute 2Leukemia, Myeloid, Accelerated Phase 2Blast Crisis 2Anemia, Refractory, with Excess of Blasts 2Preleukemia 1Neutropenia 1Myeloproliferative Disorders 1

Interventions

Cytarabine 16Arsenic Trioxide 11Tretinoin 10Methotrexate 10Cyclophosphamide 9Idarubicin 8Filgrastim 7Mercaptopurine 6Busulfan 6fludarabine phosphate 5Etoposide 5Vorinostat 4Topotecan 4Sorafenib 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Daunorubicin 4Clofarabine 4Granulocyte Colony-Stimulating Factor 3Gemtuzumab 3Azacitidine 3Antilymphocyte Serum 3romidepsin 2merphos 2lintuzumab 2entinostat 2Thiotepa 2Tacrolimus 2Mitoxantrone 2Lenalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Promyelocytic, Acute × lintuzumab × Clear all
NCT00002609 2013-06-24

Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
40 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00016159 2013-01-16

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
35 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡